Test To Treat Tug-of-War: Pharmacy, Physician Groups Each Have Concerns With Biden COVID Plan

Community pharmacists say widespread implementation of Biden’s rapid pill dispensing initiative necessitates allowing pharmacists to prescribe Paxlovid and molnupiravir. But AMA worries that even clinic-based prescribing puts patients at risk because it bypasses primary care doctors.

Pharmacy
Community pharmacies face hurdles in implementing COVID-19 Test to Treat initiative • Source: Alamy

Large chain pharmacies are prepared to boost the dispensing of COVID-19 oral antivirals under President Biden’s Test to Treat Initiative. But participation of smaller pharmacies may depend on a change in prescribing policy and an increase in the dispensing fees they receive – while some physicians worry that even the current plan’s emphasis on clinics puts patients at risk.

The initiative, included in the administration’s National COVID-19 Preparedness Plan, is establishing “one-stop” locations at pharmacy-based clinics, community health centers,...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Distribution/Supply Chain

More from Compliance